These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 12118962

  • 1. Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
    Peacock JE, Herrington DA, Wade JC, Lazarus HM, Reed MD, Sinclair JW, Haverstock DC, Kowalsky SF, Hurd DD, Cushing DA, Harman CP, Donowitz GR.
    Ann Intern Med; 2002 Jul 16; 137(2):77-87. PubMed ID: 12118962
    [Abstract] [Full Text] [Related]

  • 2. Summaries for patients. Treatment of fever in hospitalized patients with low white blood cell counts.
    Ann Intern Med; 2002 Jul 16; 137(2):I20. PubMed ID: 12118984
    [No Abstract] [Full Text] [Related]

  • 3. Ciprofloxacin versus tobramycin for neutropenic fevers.
    Bodey GP, Rolston KV, Raad II.
    Ann Intern Med; 2003 Mar 04; 138(5):435; author reply 436. PubMed ID: 12614101
    [No Abstract] [Full Text] [Related]

  • 4. Ciprofloxacin versus tobramycin for neutropenic fevers.
    Linkin DR, Fishman N.
    Ann Intern Med; 2003 Mar 04; 138(5):435-6; author reply 436. PubMed ID: 12614102
    [No Abstract] [Full Text] [Related]

  • 5. Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group.
    De Pauw BE, Deresinski SC, Feld R, Lane-Allman EF, Donnelly JP.
    Ann Intern Med; 1994 May 15; 120(10):834-44. PubMed ID: 8154643
    [Abstract] [Full Text] [Related]

  • 6. Piperacillin/tazobactam plus tobramycin versus ceftazidime plus tobramycin as empiric therapy for fever in severely neutropenic patients.
    Marie JP, Marjanovic Z, Vekhoff A, Bouvet A, Chast F, Levy V, Baudard M, Legrand O, Rio B, Delmer A, Zittoun R.
    Support Care Cancer; 1999 Mar 15; 7(2):89-94. PubMed ID: 10089089
    [Abstract] [Full Text] [Related]

  • 7. Cefoperazone plus piperacillin versus mezlocillin plus tobramycin as empiric therapy for febrile episodes in neutropenic patients.
    Rotstein C, Cimino M, Winkey K, Cesari C, Fenner J.
    Am J Med; 1988 Jul 25; 85(1A):36-43. PubMed ID: 3041817
    [Abstract] [Full Text] [Related]

  • 8. Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation.
    Philpott-Howard J, Burroughs A, Fisher N, Hastings M, Kibbler C, Mutimer D, Patch D, Rolando N, Wade J, Wendon J, O'Grady J.
    J Antimicrob Chemother; 2003 Dec 25; 52(6):993-1000. PubMed ID: 14585863
    [Abstract] [Full Text] [Related]

  • 9. Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients.
    Hess U, Böhme C, Rey K, Senn HJ.
    Support Care Cancer; 1998 Jul 25; 6(4):402-9. PubMed ID: 9695210
    [Abstract] [Full Text] [Related]

  • 10. A randomized study of teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin for the empirical treatment of fever in neutropenic patients.
    Kelsey SM, Collins PW, Delord C, Weinhard B, Newland AC.
    Br J Haematol; 1990 Dec 25; 76 Suppl 2():10-3. PubMed ID: 2149044
    [Abstract] [Full Text] [Related]

  • 11. Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.
    Kureishi A, Jewesson PJ, Rubinger M, Cole CD, Reece DE, Phillips GL, Smith JA, Chow AW.
    Antimicrob Agents Chemother; 1991 Nov 25; 35(11):2246-52. PubMed ID: 1839490
    [Abstract] [Full Text] [Related]

  • 12. Ultraviolet recall-like phenomenon occurring after piperacillin, tobramycin, and ciprofloxacin therapy.
    Krishnan RS, Lewis AT, Kass JS, Hsu S.
    J Am Acad Dermatol; 2001 Jun 25; 44(6):1045-7. PubMed ID: 11369921
    [No Abstract] [Full Text] [Related]

  • 13. Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.
    Sanz MA, López J, Lahuerta JJ, Rovira M, Batlle M, Pérez C, Vázquez L, Julià A, Palau J, Gutiérrez M, Capote FJ, Ramos F, Benlloch L, Larrea L, Jarque I, Spanish PETHEMA Group.
    J Antimicrob Chemother; 2002 Jul 25; 50(1):79-88. PubMed ID: 12096010
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial of Timentin and tobramycin versus piperacillin and tobramycin in febrile neutropenic patients.
    Mackie MJ, Reilly JT, Purohit S, Bartzokas CA.
    J Antimicrob Chemother; 1986 May 25; 17 Suppl C():219-24. PubMed ID: 3522529
    [Abstract] [Full Text] [Related]

  • 15. Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors.
    Düzova A, Kutluk T, Kanra G, Büyükpamukçu M, Akyüz C, Seçmeer G, Ceyhan M.
    Turk J Pediatr; 2001 May 25; 43(2):105-9. PubMed ID: 11432485
    [Abstract] [Full Text] [Related]

  • 16. Ciprofloxacin plus piperacillin is an equally effective regimen for empiric therapy in febrile neutropenic patients compared with standard therapy.
    Griggs JJ, Blair EA, Norton JR, Rowe JM, Flesher WR, Betts RF.
    Am J Hematol; 1998 Aug 25; 58(4):293-7. PubMed ID: 9692392
    [Abstract] [Full Text] [Related]

  • 17. Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
    Gorschlüter M, Hahn C, Fixson A, Mey U, Ziske C, Molitor E, Horré R, Sauerbruch T, Marklein G, Schmidt-Wolf IG, Glasmacher A.
    Support Care Cancer; 2003 Jun 25; 11(6):362-70. PubMed ID: 12690546
    [Abstract] [Full Text] [Related]

  • 18. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children.
    Aksoylar S, Cetingül N, Kantar M, Karapinar D, Kavakli K, Kansoy S.
    Pediatr Hematol Oncol; 2004 Mar 25; 21(2):115-23. PubMed ID: 15160510
    [Abstract] [Full Text] [Related]

  • 19. Piperacillin/tazobactam monotherapy versus piperacillin/tazobactam plus amikacin as initial empirical therapy for febrile neutropenia in children with acute leukemia.
    Zengin E, Sarper N, Kılıç SC.
    Pediatr Hematol Oncol; 2011 May 25; 28(4):311-20. PubMed ID: 21524156
    [Abstract] [Full Text] [Related]

  • 20. Randomized controlled trial of once- versus thrice-daily tobramycin in febrile neutropenic children undergoing stem cell transplantation.
    Sung L, Dupuis LL, Bliss B, Taddio A, Abdolell M, Allen U, Rolland M, Tong A, Taylor T, Doyle J.
    J Natl Cancer Inst; 2003 Dec 17; 95(24):1869-77. PubMed ID: 14679156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.